The nutraceutical role of thePhaseolus vulgarisα-amylase inhibitor
- 1 July 2008
- journal article
- review article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 100 (1), 1-12
- https://doi.org/10.1017/s0007114508879135
Abstract
The present review assesses the potential of thePhaseolus vulgarisα-amylase inhibitor isoform 1 (α-AI1) starch blockers as a widely used remedy against obesity and diabetes. Consumption of the α-amylase inhibitor causes marginal intraluminal α-amylase activity facilitated by the inhibitor's appropriate structural, physico-chemical and functional properties. As a result there is decreased postprandial plasma hyperglycaemia and insulin levels, increased resistance of starch to digestion and increased activity of colorectal bacteria. The efficacy and safety of the amylase inhibitor extracts, however, depend on the processing and extraction techniques used. The extracts are potential ingredients in foods for increased carbohydrate tolerance in diabetics, decreased energy intake for reducing obesity and for increased resistant starch. Research developments in the distribution and biosynthesis of the α-amylase inhibitor, relevant physico-chemical properties, the molecular starch-blocking mechanism, anti-obesity and anti-diabetes effects, safety of extracts and the need for research into their potential anti-colorectal cancer effect are discussed.Keywords
This publication has 98 references indexed in Scilit:
- Non-nutrient bioactive substances of pulsesBritish Journal of Nutrition, 2002
- Molecular basis for the specific binding of different α-amylase inhibitors from Phaseolus vulgaris seeds to the active site of α-amylasePlant Physiology and Biochemistry, 2000
- Evaluation of antinutritional factors of selected varieties ofPhaseolus vulgarisJournal of the Science of Food and Agriculture, 1999
- Insecticidal activity of an α-amylase inhibitor-like protein resembling a putative precursor of α-amylase inhibitor in the common bean, Phaseolus vulgaris L.Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1999
- Post‐translational processing of two α‐amylase inhibitors and an arcelin from the common bean, Phaseolus vulgarisFEBS Letters, 1999
- Characterization and functional properties of the α-amylase inhibitor (α-AI) from kidney bean (Phaseolus vulgaris) seedsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1997
- Analysis of sequence variation among legume lectins: A ring of hypervariable residues forms the perimeter of the carbohydrate-binding siteJournal of Molecular Biology, 1992
- Resistance of cranberry bean (Phaseolus vulgaris) α-amylase inhibitor to intraluminal digestion and its movement along rat gastrointestine: Further investigation using a radioactive probe and specific antiserumFood Chemistry, 1991
- Occurrence and purification of .alpha.-amylase isoinhibitors in bean (Phaseolus vulgaris L.) varietiesJournal of Agricultural and Food Chemistry, 1991
- Starch Blockers — Their Effect on Calorie Absorption from a High-Starch MealThe New England Journal of Medicine, 1982